Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus

NCT00941161 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: metformin/glimepiride combination
DRUG: metformin
DRUG: glimepiride

Sponsor

Laboratorios Silanes S.A. de C.V.